Workflow
Drug combination therapy
icon
搜索文档
Madrigal Pharmaceuticals(MDGL) - 2025 Q3 - Earnings Call Transcript
2025-11-04 22:00
Madrigal Pharmaceuticals (NasdaqGS:MDGL) Q3 2025 Earnings Call November 04, 2025 08:00 AM ET Speaker5Good morning, and thank you for standing by. Welcome to the Madrigal Pharmaceuticals third quarter 2025 earnings conference call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question-and-answer session. As a reminder, today's conference call is being recorded. I'd like to introduce Ms. Tina Ventura, Chief Investor Relations Officer. Please go ahea ...